Top View
- Spice Overview
- Stembook 2018.Pdf
- Spice’ Phenomenon 1
- Cannabinoids Prevent Emesis Produced by the Cannabinoid CB1 Receptor Antagonist/ Inverse Agonist SR 141716A Nissar A
- House Bill No. 2038
- Scheduling: Delegates' Reasons for Final Decisions
- Cesamet) Reference Number: CP.PMN.160 Effective Date: 11.16.16 Last Review Date: 02.21 Line of Business: Commercial, Medicaid Revision Log
- Billing Code 4410-09-P DEPARTMENT of JUSTICE DRUG
- Schedules of Controlled Substances in Conflict Herewith Are Hereby Repealed
- Mind Altering… Synthetic (Designer) and Naturally Occuring…Drugs
- House Bill No. 2038
- Synthetic Cannabinoids in Herbal Products Background
- Behavioral Effects of Levonantradol and Nantradol in the Rhesus Monkey
- Testing for 'Spice' and Everything Nice
- Future of Cannabis and Cannabinoids in Therapeutics
- Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential
- Nabilone Decreases Marijuana Withdrawal and a Laboratory Measure of Marijuana Relapse
- CANNABINOIDS Cesamet (Nabilone), Marinol (Dronabinol) Capsules, Syndros (Dronabinol) Oral Solution
- Federal Register/Vol. 78, No. 35/Thursday, February 21, 2013
- Pros and Cons of the Cannabinoid System in Cancer: Focus on Hematological Malignancies
- List of Scheduling Actions, Controlled Substances And
- Oklahoma Drug Statutes (Listed in Numerical Order)
- Imaging Cannabinoid Receptors: a Brief Collection of Covalent and Fluorescent Probes for CB1 and CB2 Receptors
- (12) Patent Application Publication (10) Pub. No.: US 2005/0266061 A1 Stinchcomb Et Al
- NABILONE for Your Next Dose, Do Not Double the What Other PRECAUTIONS Should Dose, Just Carry on with Your Regular You Follow While Using This Drug?
- Therapeutic Applications Based on Cannabinoids Action
- Federal Register/Vol. 86, No. 77/Friday, April 23, 2021/Notices
- The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human
- Targeting the Endocannabinoid CB1 Receptor to Treat Body
- ... If You Have Issues Viewing Or Accessing This File Contact Us At
- Material Designs Toward a Synthetic Cannabinoid Sensor
- Cannabinoid Receptor Localization in Brain (Tetrahydrocannabinol/Autoradiography/Basal Ganglla/Hippocampus/Cerebeilum) MILES HERKENHAM*T, ALLISON B
- “Legal Highs” Coming to America Endocannabinoid System Basics
- Systematic Review of Systematic Reviews on Medical Cannabinoids for Pain, Nausea/Vomiting, Spasticity, and Harms: Appendix
- Cannabinoids in Medicine: a Review of Their Therapeutic Potential
- Contrasting Effects of WIN 55212–2 on Motility of the Rat Bladder and Uterus
- Classical and Nonclassical Cannabinoids: Mechanism of Action-Brain Binding Delta-9-THC Nabilonc Alljn C
- Mast Cells Express a Peripheral Cannabinoid Receptor with Differential Sensitivity to Anandamide and Palmitoylethanolamide L
- Beyond THC: the New Generation of Cannabinoid Designer Drugs
- Legal Controls on Synthetic Cannabinoids : an International Dilemma
- WHO Expert Committee on Drug Dependence Critical Review
- Pharmacology, Toxicology, and Adverse Effects of Synthetic Cannabinoid Drugs
- Synthetic Drugs Are Dangerous, Possibly Deadly, Impacting Our Communities and Available at Your Corner Stores
- Cannabinoids: Overview 1-8 a Crawley BSP, M Lebras Pharm D, L Regier BSP © Aug 2021
- Evaluation of Cannabinoid Receptor Interaction of Anandamide, the Endogenous Cannabinoid Receptor Ligand
- Medicinal Chemistry of Cannabinoids
- And Reward Systems MILES HERKENHAM Sectrim on Fututional Neuraana~Y National Institutzr of Mend Hmlth Bui~Iiiqg36, Room 20-15 &The&, Matyhnd 20892
- ACMD Report on the Major Cannabinoid Agonists ACMD Advisory Council on the Misuse of Drugs
- CESAMET (Nabilone) Capsules for Oral Administration
- Chapter CSB 2
- Drugs of Abuse (2017 Edition)
- Medicinal Cannabis for the Prevention Or Management of Nausea and Vomiting in Australia
- Federal Register/Vol. 81, No. 193/Wednesday, October 5, 2016
- Redalyc.Therapeutic Properties of Cannabinoid Drugs and Marijuana